한국지질동맥경화학회 학술대회

This session is a joint session by Latin America and the Korean Society of Lipid and Atherosclerosis (KSoLA), and will address various genetic and environmental factors related to cardiovascular diseases. Professor Hokyou Lee from Yonsei University will discuss atherosclerotic cardiovascular disease and its risk factors in cancer patients. Professor Rodrigo Alonso from Center for Advanced Metabolic Medicine and Nutrition will present research on familial Hypercholesterolemia conducted in the Latam region. Professor Pablo Corral from FASTA University will cover past and current research on Lipoprotein(a), as well as future research directions. Finally, Professor Alvaro Avezum from Sao Paulo University will deliver a lecture on dietary interventions in cardiovascular diseases.

This session is a joint session of the Oman Society of Lipid and Atherosclerosis (OSLA) and the Korean Society of Lipid and Atherosclerosis (KSoLA) and will be held under the theme "Addressing Unmet Needs Among High-Risk Patients With Atherosclerotic Cardiovascular Disease With Novel Lipid-Lowering Therapies". The session will feature in-depth presentations and discussions on the need for novel lipid-lowering therapies in high-risk patients, with speakers from Oman and Korea. In particular, the President and Vice President of OSLA will present the latest findings on residual risk in diabetic patients and unmet needs in familial hypercholesterolemia in Oman and the Middle East. This session aims to provide insight into the current status and characteristics of lipid atherosclerosis in Korea and Oman. Despite being located in the same region of Asia, these two countries differ significantly in terms of geography, society, and culture. This discussion will be highly valuable for the exchange of knowledge on lipid atherosclerosis between Korea and Oman.

This session will be a joint endeavor between the Malaysian Society of Atherosclerosis and the Korean Society of Lipid and Atherosclerosis (KSoLA), focusing on the metabolic aspects of atherosclerosis. The first speaker, Professor Yoon Kyung Cho from University of Ulsan, will present the latest research on the relationship between metabolites, organ crosstalk, and atherosclerosis. The second speaker, Professor Kyung Mook Choi from Korea University, will discuss the impact of various organokines on atherosclerosis. Lastly, Professor Lim Lee-Ling from University Malaya Medical Centre will address the topics of metabolic-associated fatty liver disease, obesity, and atherosclerosis. Given the recent epidemiological findings that highlight diabetes, obesity, and metabolic-associated fatty liver disease as major contributors to atherosclerosis, we anticipate that this session will be highly beneficial for all attendees.

This session will discuss novel therapeutic targets in atherosclerosis. The first lecture will introduce gene editing technology for treating dyslipidemia and atherosclerosis, presented by Professor Giuseppe Danilo Norata from the University of Milan. Following this, Professor Jin Won Kim from Korea University will present targeted treatment strategies for atherosclerotic plaque using intravascular imaging. Lastly, Professor Alberico L. Catapano from the University of Milan and IRCCS Multimedica will deliver a lecture about the LDL burden for cardiovascular prevention. This session aims to present the latest research and innovative therapeutic approaches for patients with atherosclerosis.